Literature DB >> 8026492

DNA replication in vitro by recombinant DNA-polymerase-alpha-primase.

F Stadlbauer1, A Brueckner, C Rehfuess, C Eckerskorn, F Lottspeich, V Förster, B Y Tseng, H P Nasheuer.   

Abstract

DNA-polymerase-alpha--primase complex contains four subunits, p180, p68, p58, and p48, and comprises a minimum of two enzymic functions. We have cloned cDNAs encoding subunits of DNA-polymerase-alpha--primase from human and mouse. Sequence comparisons showed high amino acid conservation among the mammalian proteins. We have over-expressed the single polypeptides and co-expressed various subunit complexes using baculovirus vectors, purified the proteins and investigated their biochemical properties. The purified mouse p48 subunit (Mp48) alone had primase activity. Purification of co-expressed Mp48 and Mp58 subunits yielded stable DNA primase of high specific activity. Co-expression of all four subunits yielded large quantities of tetrameric DNA-polymerase-alpha--primase. The p180, p58 and p48 polypeptides were also co-expressed and immunoaffinity purified as a trimeric enzyme complex. The tetrameric and trimeric DNA-polymerase-alpha--primase complexes showed both DNA primase and DNA polymerase activities. The tetrameric recombinant DNA-polymerase-alpha--primase synthesized double-stranded M13 DNA and replicated polyoma viral DNA in vitro efficiently.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026492     DOI: 10.1111/j.1432-1033.1994.tb18925.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  27 in total

1.  The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex.

Authors:  K Fujii; N Yokoyama; T Kiyono; K Kuzushima; M Homma; Y Nishiyama; M Fujita; T Tsurumi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

3.  Analysis of fission yeast primase defines the checkpoint responses to aberrant S phase initiation.

Authors:  S Tan; T S Wang
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  The structural determinants of checkpoint activation.

Authors:  Christina A MacDougall; Tony S Byun; Christopher Van; Muh-ching Yee; Karlene A Cimprich
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

5.  A cell-free replication system for human polyomavirus JC DNA.

Authors:  J Nesper; R W Smith; A R Kautz; E Sock; M Wegner; F Grummt; H P Nasheuer
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Cell-specific modulation of papovavirus replication by tumor suppressor protein p53.

Authors:  D Lepik; M Ustav
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Lack of genomic imprinting of DNA primase, polypeptide 2 (PRIM2) in human term placenta and white blood cells.

Authors:  Jaewook Chung; Shengdar Tsai; Andra H James; Betty H Thames; Stephanie Shytle; Jorge A Piedrahita
Journal:  Epigenetics       Date:  2012-05-01       Impact factor: 4.528

8.  Restriction of human polyomavirus BK virus DNA replication in murine cells and extracts.

Authors:  Cathal Mahon; Bo Liang; Irina Tikhanovich; Johanna R Abend; Michael J Imperiale; Heinz P Nasheuer; William R Folk
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Continued primer synthesis at stalled replication forks contributes to checkpoint activation.

Authors:  Christopher Van; Shan Yan; W Matthew Michael; Shou Waga; Karlene A Cimprich
Journal:  J Cell Biol       Date:  2010-04-12       Impact factor: 10.539

10.  Segregation of replicative DNA polymerases during S phase: DNA polymerase ε, but not DNA polymerases α/δ, are associated with lamins throughout S phase in human cells.

Authors:  Markku Vaara; Harri Itkonen; Tomi Hillukkala; Zhe Liu; Heinz-Peter Nasheuer; Daniel Schaarschmidt; Helmut Pospiech; Juhani E Syväoja
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.